Your session is about to expire
What is Etidronate Disodium
Approved as Treatment by the FDA
Etidronic acid, commonly known as Didronel, is approved by the FDA for 7 uses such as Paget's Disease of Bone and Spinal Cord Injuries (SCI) .Effectiveness
When to interrupt dosage
The recommended amount of Etidronate Disodium is contingent upon the determined condition, such as Total Hip Replacements, Paget's Disease of Bone and Heterotopic Ossification. Dosage likewise relies upon the technique of delivery delineated in the table underneath.Warnings
Etidronate Disodium has five contraindications that preclude its utilization in combination with the conditions listed in the table below.Etidronate Disodium ContraindicationsEtidronate Disodium Novel Uses: Which Conditions Have a Clinical Trial Featuring Etidronate Disodium?
48 active clinical trials are presently being conducted to assess the usefulness of Etidronate Disodium in treating Heterotopic Ossification, Paget's Disease of Bone and Spinal Cord Injury.Etidronate Disodium Reviews: What are patients saying about Etidronate Disodium?
Patient Q&A Section about etidronate disodium
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is a disadvantage of etidronate?
"Painful, itchy blisters on the skin that peel and eventually fall off. Joint and muscle pain that is severe and occasionally prevents movement. A burning, crawling, or prickling sensation under the skin. Difficulty swallowing."
What are etidronate disodium tablets for?
"Etidronate is a medication used to treat Paget's disease, a condition which weakens and deforms bones. By slowing bone loss, etidronate helps make bones stronger and less likely to break. It also alleviates bone pain associated with Paget's disease."
When should I take etidronate?
"You should take etidronate with a full glass of water on an empty stomach at least 2 hours before or after food."
Is etidronate discontinued?
"os
This drug is no longer available in the United States. The typical dose was 7.5 mg/kg IV infusion given once every day for three days in a row. Etidronate was considered a drug for a rare condition by the FDA, but etidronate therapy has been replaced with more powerful bisphosphonates for this condition."